If one wants to use the material in a biobank for another objective than what
is covered by previous consents, then sample providers are to be informed and
new consents to be obtained for the new objective.
Research and clinical trials are, however, excluded from this requirement. If
the new objective concerns such activities, then the Research Ethics Committee
that approves of the new objective also decides what to require in terms of
information to, and consent from, sample providers.
Clarifications are still needed concerning the conditions under which the use of
a biobank is to be regarded as constituting a new objective, that is, something
that is not covered by previous consents. Some problems in fixing the boundary
can here be predicted. There is, for instance, some overlapping between clinical
diagnostic analyses and clinical developmental work
All content is © 2003 The National Biobank Program
Feedback | Privacy policy